Effects of a conventional aphrodisiac: a twenty eight day repeated administration of Sildenafil citrate graded doses on experimental rats
Abstract
Sildenafil citrate (Viagra), a phosphodiesterase-5 inhibitor (PDE5I), has long been used as a first-line oral treatment for erectile dysfunction. While it has beneficial effects on the erectile organ, it also has some negative effects on other cells and/or tissues related to the reproductive system when exposed for an extended period of time. The purpose of this study was to study the long term effect of Viagra on sperm parameters in male Wistar albino rats. Twenty (20) albino male Wistar rats were selected into four groups (n=5) randomly. The control group was administered 1 mL/kg of distilled water while 50 mg/kg, 100 mg/kg, and 200 mg/kg body weight of Sildenafil citrate were administered once in a day for 28 days to three treatment groups of rats. Oral administration was done using oropharyngeal cannula once daily for 28 days. At the end of the trial period animals were sacrificed on the 29th day, and epididymal sperm and testes were collected subject to various analytical assays. Findings showed significant reduction in sperm count and sperm normality, with a significant incremental in sperm malformations/abnormality in 28 days Viagra exposed animal when compared to the control. The testicular assay depicted histopathological alterations in testes of male rats treated with Sildenafil citrate at all dose levels. The current study clearly demonstrated that long-term use of Viagra caused changes in sperm quality and quantity, resulting in a decrease in fertility rate. It…
Read the paper
Related studies
- Drug repositioning: a brief overview
- Cyclic nucleotide phosphodiesterases in Drosophila melanogaster
- Time-resolved in silico modeling of fine-tuned cAMP signaling in platelets: feedback loops, titrated phosphorylations and pharmacological modulation
- Current View on Green Tea Catechins Formulations, Their Interactions with Selected Drugs, and Prospective Applications for Various Health Conditions
- In silico Structure-based Identification of Novel Acetylcholinesterase Inhibitors Against Alzheimer’s Disease
- Development and In Vitro Evaluation of Controlled Release Viagra® Containing Poloxamer-188 Using Gastroplus™ PBPK Modeling Software for In Vivo Predictions and Pharmacokinetic Assessments
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.